|
| Experience of Professor WANG Songling in the treatment of moyamoya disease complicated with ischemic stroke |
| Hits 2025 Download times 1200 Received:March 02, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2020.03.04 |
| Key Words
ischemic moyamoya disease;abnormal vascular network in the skull base;experience in diagnosis and treatment of traditional Chinese medicine;WANG Songling |
| Author Name | Affiliation | E-mail | | ZHAO Mengyan | Nanjing University of Chinese Medicine, Nanjing 210023, China
Nanjing Chinese Medicine Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210001, China | | | LUO Tianjiong | Nanjing University of Chinese Medicine, Nanjing 210023, China
Nanjing Chinese Medicine Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210001, China | | | WANG Songling | Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou 450003, China | xinnaoxgbz@163.com | | ZHAO Haiqi | Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou 450003, China | |
|
| Abstract
|
| Professor WANG Songling thinks that the causes of moyamoya disease are congenital endowment deficiency,acquired deprivations,or improper diet that damages acquired spleen soil,or strain that excessively damages congenital kidney essence,so the disease is mostly based on deficiency and marked with excess. This deficiency is mainly caused by spleen and kidney,and the heart and liver are injured by the disease for a long time. The marked excess is mainly caused by wind,fire,phlegm and blood stasis. Professor WANG Songling clinically classifies moyamoya disease into the syndrome of internal movement of liver wind,blood stasis,heat resistance and collateral obstruction. Syndrome of weakness of spleen and stomach,phlegm turbidity and stasis. Self-made Zhongfengling Formulation I treats the syndrome of liver wind internal movement,blood stasis,heat resistance and collateral obstruction,while Zhongfengling Formulation II treats the syndrome of spleen and kidney weakness,phlegm turbidity and blood stasis. |
|
|
|
|
|
